Thus, our findings are in accord with VSR-mediated upregulation of DCL1 and DCL1-mediated downregulation of the antivirally acting DCL4 and might indeed represent an important measure to counteract antiviral RNA silencing at the early infection stage (model in Fig. 6). The gene discussed is CD302; the disease is infection.